2,207 results on '"Conaghan, Philip"'
Search Results
2. Statin use and longitudinal changes in quantitative MRI-based biomarkers of thigh muscle quality: data from Osteoarthritis Initiative
3. 3D Bone Shape from CT-Scans Provides an Objective Measure of Osteoarthritis Severity: Data from the IMI-APPROACH Study
4. Hypergraphs for Frailty Analysis Research Paper
5. Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12-month follow up of an open-label study
6. Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis
7. Correction: Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial
8. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit
9. Fostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development
10. The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial
11. Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
12. Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials
13. Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023
14. Appraisal of quality and analysis of the similarities and differences between osteoarthritis Clinical Practice Guideline recommendations: A systematic review
15. Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets
16. Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshop
17. A preoperative package of care for osteoarthritis, consisting of weight loss, orthotics, rehabilitation, and topical and oral analgesia (OPPORTUNITY): a two-centre, open-label, randomised controlled feasibility trial
18. The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee region
19. Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis
20. Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol
21. Comparison of 3D quantitative osteoarthritis imaging biomarkers from paired CT and MR images: data from the IMI-APPROACH study
22. Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study
23. 3-dimensional bone shape and knee osteoarthritis: What have we learned?
24. Characterizing Osteophyte Formation in Knee Osteoarthritis: Application of Machine Learning Quantification of a Computerized Tomography Cohort: Implications for Treatment
25. Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension
26. Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab
27. Drug therapy of rheumatoid arthritis
28. B-cell capacity for expansion and differentiation into plasma cells are altered in osteoarthritis
29. Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session
30. Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study
31. Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial
32. Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations
33. Barriers and facilitators to engaging with a digital self‐management programme for painful distal upper limb musculoskeletal disorders: A qualitative exploratory study
34. 3 YEAR FOLLOW-UP FROM A RANDOMISED CONTROLLED TRIAL OF INTRA-ARTICULAR POLYACRYLAMIDE HYDROGEL INJECTION IN SUBJECTS WITH KNEE OSTEOARTHRITIS
35. SUSTAINED CLINICAL EFFECTS AFTER A SINGLE INTRAARTICULAR INJECTION OF PCRX201 FOR MODERATE-TO-SEVERE OSTEOARTHRITIS OF THE KNEE
36. Long-term health conditions and UK labour market outcomes during the COVID-19 pandemic
37. Statin use and MRI subchondral bone marrow lesion worsening in generalized osteoarthritis: longitudinal analysis from Osteoarthritis Initiative data
38. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit
39. Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial
40. Bone Marrow Lesions and Magnetic Resonance Imaging–Detected Structural Abnormalities in Patients With Midfoot Pain and Osteoarthritis: A Cross‐Sectional Study
41. Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study
42. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales
43. Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis
44. Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept
45. Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis
46. The usefulness of ultrasound in predicting outcomes in patients with shoulder pain: a prospective observational study.
47. Home-Based Health Care Interventions for People Aged 75 Years and Above With Chronic, Noninflammatory Musculoskeletal Pain: A Scoping Review
48. Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis
49. Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS)
50. The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.